From the Armed Forces Medical Centre Ulm, Department of Anesthesiology and Intensive Care Medicine, Section Emergency Medicine, Ulm, Germany.
J Trauma Acute Care Surg. 2021 Aug 1;91(2):344-351. doi: 10.1097/TA.0000000000003246.
Hemorrhage with trauma-induced coagulopathy (TIC) and hyperfibrinolysis (HF) increases the mortality risk after severe trauma. While TIC at hospital admission is well studied, little is known about coagulopathy at the incident site. The aim of the study was to investigate coagulation disorders already present on scene.
In a prospective single-center observational study, blood samples of trauma patients obtained before and at hospital admission were analyzed. Data on rotational thromboelastometry, blood gas analysis, prehospital treatment, injury severity, in-hospital blood transfusions, and mortality were investigated according to the presence of coagulation disorders at the incident site. The patients were divided into three groups according to the presence of coagulation disorders (no coagulopathy, TIC, TIC with HF). In a subgroup analysis, patients with a Trauma-Induced Coagulopathy Clinical Score (TICCS) of ≥10 were investigated.
Between August 2015 and February 2018, 148 patients were enrolled in the study. The mean Injury Severity Score was 22.1, and overall mortality was 7.4%. Trauma-induced coagulopathy and HF were already detectable at the incident site in 18.2% and 6.1%, respectively. Patients with HF had significantly altered circulation parameters with significant changes in pH, hemoglobin, lactate, and base excess at the incident site. In patients with TICCS of ≥10 (14.2%), TIC was detected in 47.6% of the cases and HF in 28.6%. Furthermore, in these patients, blood gas parameters significantly changed and the need for blood transfusion and mortality.
Trauma-induced coagulopathy and HF can be detected in severely injured patients even before medical treatment is started. Furthermore, in patients with HF and TICCS of ≥10, blood gas parameters were significantly changed at the incident site.
Prognostic study, level III.
创伤诱导的凝血病(TIC)和过度纤维蛋白溶解(HF)伴发的出血会增加严重创伤患者的死亡风险。虽然入院时的 TIC 已经得到了充分的研究,但对于现场的凝血病知之甚少。本研究旨在调查现场已经存在的凝血障碍。
在一项前瞻性单中心观察性研究中,分析了创伤患者入院前和入院时采集的血液样本。根据现场是否存在凝血障碍,调查了旋转血栓弹性测定、血气分析、院前治疗、损伤严重程度、院内输血和死亡率等数据。患者根据现场是否存在凝血障碍(无凝血障碍、TIC、TIC 伴 HF)分为三组。在亚组分析中,对创伤诱导凝血病临床评分(TICCS)≥10 的患者进行了研究。
2015 年 8 月至 2018 年 2 月,共纳入 148 例患者。平均损伤严重程度评分(ISS)为 22.1,总体死亡率为 7.4%。TIC 和 HF 分别在 18.2%和 6.1%的患者中可在现场检测到。HF 患者在现场的循环参数明显改变,pH 值、血红蛋白、乳酸和碱剩余均有显著变化。在 TICCS≥10(14.2%)的患者中,47.6%的患者存在 TIC,28.6%的患者存在 HF。此外,在这些患者中,血气参数明显改变,需要输血和死亡率增加。
即使在开始治疗之前,严重创伤患者也可检测到创伤诱导的凝血病和 HF。此外,在 HF 患者和 TICCS≥10 的患者中,现场的血气参数明显改变。
预后研究,III 级。